IL10 and Alzheimer disease: Analysis of variance applied on the data taken from the CON and PRO groups showed that treatment of the AD patients with the probiotic supplementation not significantly affected TNF-α [F(3, 63) = 0.64; P > 0.05], IL-6 [F(3, 71) = 0.27; P > 0.05], and IL-10 [F(3, 63) = 0.64; P > 0.05].